Worth reading
86Important
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
1194
¥ million (year-on-year increase in FY2026 revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Earnings presentationFiscal year ending September 2026, full year8 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥31,105 million+4.0%
Operating profit¥2,625 million-10.9%
Ordinary income¥3,055 million+0.9%
Net income¥2,224 million-34.6%
Gross Profit Margin73.3 %
Operating profit margin8.4 %
Selling, general and administrative expenses¥20,182 million
Results for the three months of the current quarterQuarter-only trends in revenue and operating profit by segment are presented. Quarter-only consolidated income statement results: Not disclosed
Full-year earnings forecast
Net Sales
¥33,000 million
Operating profit
¥2,800 million
Ordinary income
¥2,800 million
Net income
¥700 million
Dividends
20 yen per share
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
FY2026 revenue98.7 %
FY2026 operating income97.2 %
FY2026 ordinary profit98.6 %
FY2026 net income83 %
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Both revenue and operating profit were broadly in line with the plan. Revenue through ordinary profit was broadly in line with the plan, while net profit fell below plan.Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Net Sales
Healthcare and School DX revenue growthamount not disclosed
Operating profit
Higher Cost Burden in the Healthcare Businessamount not disclosed
Ordinary income
Increase in equity in earnings of affiliates¥362 million
Net income
Decrease in Consumption Tax Refunds, etc.¥-1,248 million
Software Impairment Losses, etc.amount not disclosed
New initiatives
- Next-generation AI cloud medical claims processing system scheduled to go on sale in January
- Development of an AI-powered automatic summarisation function and cloud-based inventory management
- Multiple rollouts of the parenting DX service
- Expansion of adoption among private and public schools
- Negotiations on a partnership agreement with municipalities and the introduction of fees for the Luna Luna Mirai Support service
Key KPIsA metric the company considers important as a management benchmark.
- Paid members358 10,000 peopleYear on year against the same period last yearFlat
- Paying subscribers to security-related applications133 10,000 people
- Stores using the cloud medication-record system5,094 storesYear on year against the same period last year+351 stores compared with the immediately preceding quarter
- Municipalities using the maternal and child health handbook app912 Local governments
- Number of municipalities adopting the parenting DX service427 Local governments
- Number of private schools using the service1,359 classrooms
- Private-school share50 %
- Municipal share52 %
Segment results
Content Business
Net Sales
FY2025¥17,314 million
FY2026¥16,429 million
Operating profit
FY2025¥4,270 million
FY2026¥4,655 million
Year on yearRevenue Decline and Profit Growth
Healthcare Business
Net Sales
FY2025¥6,676 million
FY2026¥7,786 million
Operating profit
FY2025¥-80 million
FY2026¥-1,043 million
Year on yearHigher revenue, lower profit (wider loss)
School DX business
Net Sales
FY2025¥1,890 million
FY2026¥2,444 million
Operating profit
FY2025¥550 million
FY2026¥759 million
Year on yearHigher revenue and higher profit
Other businesses
Net Sales
FY2025¥5,539 million
FY2026¥6,019 million
Operating profit
FY2025¥949 million
FY2026¥977 million
Year on yearHigher revenue, broadly flat profit
Medium-term management plan targets
FY2029 Consolidated Operating Profit
¥50 100 million
Market Size / Share
Private-school share50 %
Maternal and Child Health Handbook App: Municipal Share52 %
Annual Dividend
Fiscal year ending September 2026
Annual20 yen per share
Interim10 yen per share
End of period10 yen per share
Fiscal year ending September 2027
Annual20 yen per share
Interim10 yen per share
End of period10 yen per share
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Fiscal year ending September 2026, full year |
| Net Sales | ¥31,105 million (YoY +4.0%) |
| Operating profit | ¥2,625 million (YoY -10.9%) |
| Ordinary income | ¥3,055 million (YoY +0.9%) |
| Net income | ¥2,224 million (YoY -34.6%) |
| Gross Profit Margin | 73.3 % |
| Operating profit margin | 8.4 % |
| Selling, general and administrative expenses | ¥20,182 million |
| Results for the three months of the current quarter | Quarter-only trends in revenue and operating profit by segment are presented. Quarter-only consolidated income statement results: Not disclosed |
| Full-year earnings forecast | Net Sales ¥33,000 million / Operating profit ¥2,800 million / Ordinary income ¥2,800 million / Net income ¥700 million / Dividends 20 yen per share |
| Progress against full-year forecast | FY2026 revenue 98.7 % / FY2026 operating income 97.2 % / FY2026 ordinary profit 98.6 % / FY2026 net income 83 % |
| Self-assessment against the plan | Both revenue and operating profit were broadly in line with the plan. Revenue through ordinary profit was broadly in line with the plan, while net profit fell below plan. |
| Segment results | Content Business Net Sales FY2025 ¥17,314 million / FY2026 ¥16,429 million / Operating profit FY2025 ¥4,270 million / FY2026 ¥4,655 million / Year on year Revenue Decline and Profit Growth / Healthcare Business Net Sales FY2025 ¥6,676 million / FY2026 ¥7,786 million / Operating profit FY2025 ¥-80 million / FY2026 ¥-1,043 million / Year on year Higher revenue, lower profit (wider loss) / School DX business Net Sales FY2025 ¥1,890 million / FY2026 ¥2,444 million / Operating profit FY2025 ¥550 million / FY2026 ¥759 million / Year on year Higher revenue and higher profit / Other businesses Net Sales FY2025 ¥5,539 million / FY2026 ¥6,019 million / Operating profit FY2025 ¥949 million / FY2026 ¥977 million / Year on year Higher revenue, broadly flat profit |
| Breakdown of Factors Affecting the Change | Net Sales Healthcare and School DX revenue growth amount not disclosed / Operating profit Higher Cost Burden in the Healthcare Business amount not disclosed / Ordinary income Increase in equity in earnings of affiliates ¥362 million / Net income Decrease in Consumption Tax Refunds, etc. ¥-1,248 million / Software Impairment Losses, etc. amount not disclosed |
| Key KPIs | Indicator name Paid members / Value 358 10,000 people / Year on year against the same period last year Flat, Indicator name Paying subscribers to security-related applications / Value 133 10,000 people / Year on year against the same period last year Not disclosed, Indicator name Stores using the cloud medication-record system / Value 5,094 stores / Year on year against the same period last year +351 stores compared with the immediately preceding quarter, Indicator name Municipalities using the maternal and child health handbook app / Value 912 Local governments / Year on year against the same period last year Not disclosed, Indicator name Number of municipalities adopting the parenting DX service / Value 427 Local governments / Year on year against the same period last year Not disclosed, Indicator name Number of private schools using the service / Value 1,359 classrooms / Year on year against the same period last year Not disclosed, Indicator name Private-school share / Value 50 % / Year on year against the same period last year Not disclosed, Indicator name Municipal share / Value 52 % / Year on year against the same period last year Not disclosed |
| Medium-term management plan targets | FY2029 Consolidated Operating Profit ¥50 100 million |
| Annual Dividend | Fiscal year ending September 2026 Annual 20 yen per share / Interim 10 yen per share / End of period 10 yen per share / Fiscal year ending September 2027 Annual 20 yen per share / Interim 10 yen per share / End of period 10 yen per share |
| Market Size / Share | Private-school share 50 % / Maternal and Child Health Handbook App: Municipal Share 52 % |
| New initiatives | Next-generation AI cloud medical claims processing system scheduled to go on sale in January, Development of an AI-powered automatic summarisation function and cloud-based inventory management, Multiple rollouts of the parenting DX service, Expansion of adoption among private and public schools, Negotiations on a partnership agreement with municipalities and the introduction of fees for the Luna Luna Mirai Support service |
Items this document does not state (11)
Unit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In FY2026, revenue growth in the healthcare and school DX businesses contributed to higher revenue. Operating profit declined due to increased cost burdens in the healthcare business, while net profit declined due to lower consumption tax refunds and other factors, including software impairment losses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.